Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 22, 2023Levaquin 750MG IN D5W 150MLLack of sterility assuranceSentara Infusion Services · D-0301-2023Class IITerminatedFeb 22, 2023Lactated RingersLack of sterility assuranceSentara Infusion Services · D-0300-2023Class IITerminatedFeb 22, 2023KYTRIL 350MCG IN 3.5ML NS SYRINGELack of sterility assuranceSentara Infusion Services · D-0299-2023Class IITerminatedFeb 22, 2023INTRALIPID 18GMLack of sterility assuranceSentara Infusion Services · D-0298-2023Class IITerminatedFeb 22, 2023IMIPENEM/CILASTATIN 2000MG IN NS 400MLLack of sterility assuranceSentara Infusion Services · D-0297-2023Class IITerminatedFeb 22, 2023HYDROMORPHONELack of sterility assuranceSentara Infusion Services · D-0296-2023Class IITerminatedFeb 22, 2023HYDROCORTISONE 9a) 2MG IN NS 0.2ML SYRINGELack of sterility assuranceSentara Infusion Services · D-0295-2023Class IITerminatedFeb 22, 2023GANCICLOVIRLack of sterility assuranceSentara Infusion Services · D-0294-2023Class IITerminatedFeb 22, 2023FLUCONAZOLE 200MG NS 100MLLack of sterility assuranceSentara Infusion Services · D-0293-2023Class IITerminatedFeb 22, 2023ETHANOL 70% 0.5ML SYRINGELack of sterility assuranceSentara Infusion Services · D-0292-2023Class IITerminatedFeb 22, 2023ErtapenemLack of sterility assuranceSentara Infusion Services · D-0291-2023Class IITerminatedFeb 22, 2023DOBUTAMINELack of sterility assuranceSentara Infusion Services · D-0290-2023Class IITerminatedFeb 22, 2023Diphenhydramine 18mg in 3.6ML NS SYRINGELack of sterility assuranceSentara Infusion Services · D-0289-2023Class IITerminatedFeb 22, 2023Dextrose 10% 720MLLack of sterility assuranceSentara Infusion Services · D-0288-2023Class IITerminatedFeb 22, 2023DAPTOMYCINLack of sterility assuranceSentara Infusion Services · D-0287-2023Class IITerminatedFeb 22, 2023DAPTOMYCINLack of sterility assuranceSentara Infusion Services · D-0286-2023Class IITerminatedFeb 22, 2023D5W1/2NS W/ 77MEQ OF SOD ACETATE 1000MLLack of sterility assuranceSentara Infusion Services · D-0285-2023Class IITerminatedFeb 22, 2023D5 NS 2300MLLack of sterility assuranceSentara Infusion Services · D-0284-2023Class IITerminatedFeb 22, 2023CEFTRIAXONELack of sterility assuranceSentara Infusion Services · D-0283-2023Class IITerminatedFeb 22, 2023CEFTRIAXONELack of sterility assuranceSentara Infusion Services · D-0282-2023Class IITerminatedFeb 22, 2023CEFOXITINLack of sterility assuranceSentara Infusion Services · D-0281-2023Class IITerminatedFeb 22, 2023CEFEPIMELack of sterility assuranceSentara Infusion Services · D-0280-2023Class IITerminatedFeb 22, 2023CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYRLack of sterility assuranceSentara Infusion Services · D-0279-2023Class IITerminatedFeb 22, 2023CEFAZOLINLack of sterility assuranceSentara Infusion Services · D-0278-2023Class IITerminatedFeb 22, 2023CASPOFUNGIN 50MG IN NS 100MLLack of sterility assuranceSentara Infusion Services · D-0277-2023Class IITerminatedFeb 22, 2023Ampicillin/Sulbactam 3GM IN NS 100MLLack of sterility assuranceSentara Infusion Services · D-0276-2023Class IITerminatedFeb 22, 2023AMPICILLIN 8GM IN NS 400MLLack of sterility assuranceSentara Infusion Services · D-0275-2023Class IITerminatedFeb 22, 2023AMPICILLIN 12GM IN NS 600MLack of sterility assuranceSentara Infusion Services · D-0274-2023Class IITerminatedFeb 22, 2023Amikacin 450MG IN NS 45MLLack of sterility assuranceSentara Infusion Services · D-0273-2023Class IITerminatedFeb 22, 20230.9% Sodium ChlorideLack of sterility assuranceSentara Infusion Services · D-0272-2023Class IITerminatedFeb 22, 2023Maximum Zone2 Topical AnalgesiccGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.HTO Nevada, Inc. · D-0271-2023Class IITerminatedFeb 22, 2023New & Improved Blue Gel AnestheticcGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.HTO Nevada, Inc. · D-0270-2023Class IITerminatedFeb 22, 2023Metoprolol Succinate Extended-Release TabletsFailed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint...Amerisource Health Services LLC · D-0269-2023Class IITerminatedFeb 22, 2023Thiamine Hydrochloride 3000 mg/30 mLPresence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.McGuff Compounding Pharmacy Services, Inc. · D-0267-2023Class IITerminatedFeb 22, 2023Thiamine Hydrochloride 200 mg/2mLPresence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.McGuff Compounding Pharmacy Services, Inc. · D-0266-2023Class IITerminatedFeb 15, 2023Posaconazole Delayed-Release TabletsFailed Impurities/Degradation Specifications: High Out Of Specification degradation results.Biocon Pharma Inc · D-0268-2023Class IIIOngoingFeb 15, 2023Atropine Sulfate Ophthalmic SolutionFailed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.Akorn, Inc. · D-0265-2023Class IITerminatedFeb 15, 2023Ohm Sanitizer SprayCGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Urban Electric Power · D-0264-2023Class IITerminatedFeb 15, 2023Ohm Hand SanitizerCGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Urban Electric Power · D-0263-2023Class IITerminatedFeb 8, 2023Diltiazem Hydrochloride Extended-Release CapsulesFailed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.Sun Pharmaceutical Industries Inc · D-0262-2023